More articles from Commentary

You have access
U.S. International Standards Strategies
Michael J. Miller

PDA Journal of Pharmaceutical Science and Technology July 1991, 45 (4) 181-182;
You have access
The Outer Limits of FDA Inspections
Thomas Scarlett

PDA Journal of Pharmaceutical Science and Technology July 1991, 45 (4) 204-208;
You have access
FDA Inspections in Canada
E. A. Oliver

PDA Journal of Pharmaceutical Science and Technology May 1991, 45 (3) 142-146;
You have access
Good Manufacturing Practices and Clinical Supplies
John W. Levchuk

PDA Journal of Pharmaceutical Science and Technology May 1991, 45 (3) 152-155;
You have access
Remarks by the Commissioner
David A. Kessler

PDA Journal of Pharmaceutical Science and Technology May 1991, 45 (3) 118-121;
You have access
Facility Requirements for Biotech Plants
Donald Hill and Michael Beatrice

PDA Journal of Pharmaceutical Science and Technology May 1991, 45 (3) 132-137;
You have access
Regulations, Proposals, Guidelines, Advisory Opinions, and Letters of Advice: What Legal Significance?
Linda R. Horton

PDA Journal of Pharmaceutical Science and Technology May 1991, 45 (3) 138-141;
You have access
FDA: Keynote Address, PDA/FDA Conference
Ronald G. Chesemore

PDA Journal of Pharmaceutical Science and Technology March 1991, 45 (2) 71-75;
You have access
Product Sampling—Why Bother?
William S. Schwemer

PDA Journal of Pharmaceutical Science and Technology January 1991, 45 (1) 51-55;
You have access
Pre-Approval Inspections/Investigations
Food and Drug Administration

PDA Journal of Pharmaceutical Science and Technology January 1991, 45 (1) 56-66;

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.